Your session is about to expire
← Back to Search
Motivational Interviewing and COVID-19 Symptom Monitoring System for COVID-19
N/A
Waitlist Available
Led By Mary Cwik, PhD
Research Sponsored by Johns Hopkins Bloomberg School of Public Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Tribal members who live within an approximately 1-hour radius of the Indian Health Service (IHS) /Tribal health facility within each of the three participating sites (Whiteriver, Arizona; Chinle, Arizona; Shiprock, New Mexico).
Elder participants must be ≥65 years old at the time of recruitment.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at 3-month post enrollment. (longitudinal data analysis will be used incorporating data collected at baseline, 1-month, 2-month and 3-month post enrollment. analyses will examine change from baseline at each of these timepoints).
Awards & highlights
Study Summary
This study is evaluating whether a new approach to testing for colon cancer may improve the rate of early detection.
Eligible Conditions
- COVID-19
- Coronavirus
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline at 3-month post enrollment. (longitudinal data analysis will be used incorporating data collected at baseline, 1-month, 2-month and 3-month post enrollment. analyses will examine change from baseline at each of these timepoints).
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 3-month post enrollment. (longitudinal data analysis will be used incorporating data collected at baseline, 1-month, 2-month and 3-month post enrollment. analyses will examine change from baseline at each of these timepoints).
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
CHANGE IN PROTECTIVE BEHAVIORS Over time - Recommended Practices
PROTECTIVE BEHAVIORS - Days quarantined in the past month
PROTECTIVE BEHAVIORS - Vaccine Acceptance
+2 moreSecondary outcome measures
Anxiety
Cultural Identity and Connectedness
Demographic
+2 moreTrial Design
4Treatment groups
Experimental Treatment
Group I: MotivationaI Interviewing and COVID-19 Symptom Monitoring System GroupExperimental Treatment2 Interventions
Participants in this group will receive both motivational interviewing and daily COVID-19 symptom (CS) text-based monitoring system. This group will also receive supportive services. Participants will be provided with referrals to needed medical, mental or behavioral health care and a hygiene kit containing basic hygiene supplies. Additionally, participants will be provided with information on COVID-19 and nearby testing locations. This will include basic information about COVID-19, mask-wearing, how to prevent the spread in the home and managing stress during COVID-19.
Group II: MotivationaI Interviewing GroupExperimental Treatment2 Interventions
Participants in this study group will receive a brief, culturally appropriate, and age-tailored motivational interviewing (MI) intervention targeting facilitators and barriers to appropriate testing, isolation, and care-seeking among young adults and elders. This group will also receive supportive services. Participants will be provided with referrals to needed medical, mental, or behavioral health care and a hygiene kit containing basic hygiene supplies. Additionally, participants will be provided with information on COVID-19 and nearby testing locations. This will include basic information about COVID-19, mask-wearing, how to prevent the spread in the home and managing stress during COVID-19.
Group III: Control GroupExperimental Treatment1 Intervention
Participants in this group will only receive supportive services. Participants will be provided with referrals to needed medical, mental or behavioral health care and a hygiene kit containing basic hygiene supplies. Additionally, participants will be provided with information on COVID-19 and nearby testing locations. This will include basic information about COVID-19, mask wearing, how to prevent the spread in the home and managing stress during COVID-19
Group IV: COVID-19 Symptom Monitoring System GroupExperimental Treatment2 Interventions
Participants in this study group will receive daily COVID-19 symptom (CS) text-based monitoring system to prompt more rapid testing at the onset of symptoms. This group will also receive supportive services. Participants will be provided with referrals to needed medical, mental or behavioral health care and a hygiene kit containing basic hygiene supplies. Additionally, participants will be provided with information on COVID-19 and nearby testing locations. This will include basic information about COVID-19, mask-wearing, how to prevent the spread in the home and managing stress during COVID-19.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
COVID-19 Symptom Monitoring System
2021
N/A
~70
Motivational Interviewing and COVID-19 Symptom Monitoring System
2021
N/A
~70
Motivational Interviewing
2020
Completed Phase 3
~8850
Find a Location
Who is running the clinical trial?
Johns Hopkins Bloomberg School of Public HealthLead Sponsor
410 Previous Clinical Trials
2,116,886 Total Patients Enrolled
5 Trials studying COVID-19
3,300 Patients Enrolled for COVID-19
Mary Cwik, PhDPrincipal InvestigatorJohns Hopkins University
4 Previous Clinical Trials
719 Total Patients Enrolled
Laura Hammitt, MDPrincipal InvestigatorJohns Hopkins University
3 Previous Clinical Trials
1,033 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger